These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and car...
Tests based on the detection of mycobacterial lipoarabinomannan (LAM) antigen in urine have
emerged as potential point-of-care tests for tuberculosis (TB). LAM antigen is a lipopolysaccharide
present in mycobacterial cell walls, which is released from metabolically active or degenerating
bacterial cells ...
The Consolidated guidelines on HIV testing services bring together existing guidance relevant to the provision of HIV testing services (HTS) and addresses issues and elements for effective delivery of HTS that are common in a variety of settings, contexts and diverse populations. In addition, this docume...
This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral pre-exposure prophylaxis (PrEP) is recomme...
Martínez, E;
Jódar, Gimeno, E;
Reyes, García, R;
Carpintero, P;
Casado, JL;
Del, Pino, Montes, J;
Domingo, Pedrol, P;
Estrada, V;
Maalouf, J;
Negredo, E;
Ocampo, A;
Muñoz-Torres, M.
"OBJECTIVE:
To provide practical recommendations for the evaluation and treatment of metabolic bone disease in human immunodeficiency virus (HIV) patients.
PARTICIPANTS:
Members of scientific societies related to bone metabolism and HIV: Grupo de Estudio de Sida (GeSIDA), Sociedad Española de Endocrino...
Algorithms,
Bone Diseases, Metabolic,
HIV Infections,
Osteoporosis,
Bone Diseases, Metabolic/complications,
Bone Diseases, Metabolic/diagnosis,
Bone Diseases, Metabolic/therapy,
Osteoporosis/complications,
Osteoporosis/diagnosis,
Osteoporosis/therapy
Despite the exponential growth in the literature on modelling and simulation studies of impact and cost-effectiveness in different aspects of healthcare, there is no clear consensus on the appropriate role of modelling in the development of recommendations in clinical guidelines. This is compounded both ...
During 9–12 March 2014, WHO convened a meeting of the Guideline Development Group (GDG) comprising 52 individuals representing a wide range of stakeholders, for the purpose of reviewing, and where appropriate, revising its Medical eligibility criteria for contraceptive use, fourth edition (MEC) guidanc...
In this second supplement (December 2014) to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, recommendations from two guideline development processes are included: post-exposure prophylaxis for HIV; the use of co-trimoxazole prophylaxis for H...
Determinar cuál es el mejor algoritmo de diagnóstico en adolescentes y adultos, con infección por VIH/Sida.
Establecer qué valoraciones clínicas y de laboratorio debe incluir la valoración inicial del paciente con diagnóstico de VIH/Sida. Determinar cuál debe ser el tiempo oportuno para el inicio...
